Involvement of regucalcin in lipid metabolism and diabetes

Metabolism: Clinical and Experimental

Volumn 62, Issue 8, 2013, Pages 1045-1051

  Yamaguchi, Masayoshi ^a   Murata, Tomiyasu ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Diabetes; Insulin resistance; Lipid metabolic disorder; Regucalcin; RGN

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FATTY ACID; GLUCOSE; GLUCOSE TRANSPORTER 2; GLYCOGEN; INSULIN; INSULIN RECEPTOR; LEPTIN; LIPID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPID; REGUCALCIN; TRIACYLGLYCEROL;

CALCIUM HOMEOSTASIS; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DISEASE COURSE; GENE EXPRESSION; GLUCOSE TOLERANCE; GLUCOSE UTILIZATION; GLYCOGEN ANALYSIS; HUMAN; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIVER; LIVER CELL; LIVER FIBROSIS; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

DEOXYRIBONUCLEIC ACID; DIABETES; DNA; HDL; HEPATIC STELLATE CELLS; HEPG2; HIGH-DENSITY LIPOPROTEIN; HSCS; HUMAN HEPATOMA CELLS; INSULIN RESISTANCE; KNOCKOUT; KO; LDL; LIPID METABOLIC DISORDER; LOW-DENSITY LIPOPROTEIN; NAFLD; NONALCOHOLIC FATTY LIVER DISEASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA; PHOSPHATIDYLINOSITOL 3-KINASE; PI3K; PPAR-Γ; REGUCALCIN; RGN; RIBONUCLEIC ACID; RNA; SENESCENCE MARKER PROTEIN-30; SMP30; STREPTOZOTOCIN; STZ; TG; TRANSGENIC;

ANIMALS; CALCIUM-BINDING PROTEINS; DIABETES MELLITUS; FATTY LIVER; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; LIPID METABOLISM DISORDERS; LIVER;

EID: 84880571640     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2013.01.023     Document Type: Review

References (54)

1. M. Yamaguchi, and T. Yamamoto Purification of calcium binding substance from soluble fraction of normal rat liver Chem Pharm Bull 26 1978 1915 1918
2. 2 +-calmodulin Chem Pharm Bull 33 1985 4489 4493
3. 2 + effect Chem Pharm Bull 36 1988 321 325
4. 2 + Chem Pharm Bull 35 1987 2581 2584
5. 2 +-binding protein regucalcin and calcium inhibition. Regulatory role in liver cell function K. Kohama, Calcium inhibition 1992 Japan Sci Soc Press, Tokyo and CRC Press Boca Raton 19 41
6. T. Fujita, K. Uchida, and N. Maruyama Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver Biochim Biophys Acta 1116 1992 122 128
7. T. Fujita, T. Shirasawa, K. Uchida, and N. Maruyama Isolation of cDNA clone encoding rat senescence marker protein-30 (SMP30) and its tissue distribution Biochim Biophys Acta 1132 1992 297 305
8. N. Shimokawa, Y. Matsuda, and M. Yamaguchi Genomic cloning and chromosomal assignment of rat regucalcin gene Mol Cell Biochem 151 1995 157 163
9. D.L. Thiselton, J. McDowall, O. Brandau, J. Ramser, F. d'Esposito, and S.S. Bhattacharga An integrated, functionally annotated gene map of the DXS8026-ELK1 internal on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders Genomics 79 2002 560 572
10. N. Shimokawa, and M. Yamaguchi Molecular cloning and sequencing of the cDNA coding for a calcium-binding protein regucalcin from rat liver FEBS Lett 327 1993 251 255
11. 2 +-binding protein regucalcin is highly conserved in vertebrate species Int J Mol Med 6 2000 191 196
12. N. Shimokawa, and M. Yamaguchi Calcium administration stimulates the expression of calcium-binding protein regucalcin mRNA in rat liver FEBS Lett 305 1992 151 154
13. 2 +-binding protein regucalcin Biochem J 329 1998 157 163
14. 2 +-binding protein regucalcin. Transcriptional regulation by signaling factors. J Biol Chem 274 1999 1277 1285
15. M. Yamaguchi Novel protein RGPR-p117: its role as the regucalcin gene transcription factor Mol Cell Biochem 327 2009 53 63
16. M. Yamaguchi The transcriptional regulation of regucalcin gene expression Mol Cell Biochem 346 2011 147 171
17. 2 + in the regulation of gluconeogenesis Metabolism 48 1996 389 403
18. Hamada Y, Nagasaki H, Fuchigami M, Furuta S, Seino Y, Nakamura J, et al. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorate obesity and insulin resistance in diabetic mice. Metabolism doi:pii: S0026-0495(12)00421-0. 10.1016/j.metabol.2012.10.015.
19. 2 + Chem Pharm Bull 35 1987 2025 2029
20. 2 + effect is reversed by regucalcin Chem Pharm Bull 37 1989 388 390
21. M. Yamaguchi, M.N. Weitzman, C.A. Baile, and T. Murata Exogenous regucalcin suppresses osteoblastogenesis and stimulates adipogenesis in mouse bone marrow culture Integr Biol 4 2012 1215 1222
22. M. Yamaguchi Regucalcin and metabolic disorder: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats Mol Cell Biochem 341 2010 119 133
23. T. Murata, N. Shinya, and M. Yamaguchi Expression of calcium-binding protein regucalcin mRNA in the cloned human hepatoma cells (HepG2): stimulation by insulin Mol Cell Biochem 175 1997 163 168
24. M. Yamaguchi, K. Oishi, and M. Isogai Expression of hepatic calcium-binding protein regucalcin mRNA is elevated by refeding of fasted rats: involvement of glucose, insulin and calcium as stimulating factors Mol Cell Biochem 142 1995 35 41
25. S.S. Solomon, N. Buss, J. Shull, S. Monnier, G. Majumdar, and J. Wu Proteome of H-411E (liver) cells exposed to insulin and tumor necrosis factor-alpha: analysis of proteins involved in insulin resistance J Lab Clin Med 145 2005 275 283
26. C. Nakashima, and M. Yamaguchi Overexpression of regucalcin enhances glucose utilization and lipid production in cloned rat hepatoma H4-II-E cells: involvement of insulin resistance J Cell Biochem 99 2006 1582 1592
27. C. Nakashima, and M. Yamaguchi Overexpression of regucalc in suppresses gene expression of insulin signaling-related proteins in cloned rat hepatoma H4-II-E cells: involvement of insulin resistance Int J Mol Med 20 2007 709 716
28. M. Isogai, H. Kurota, and M. Yamaguchi Hepatic calcium-binding protein regucalcin concentration is decreased by streptozotocin-diabetic state and ethanol ingestion in rats Mol Cell Biochem 168 1997 67 72
29. G. Hasegawa, M. Yamasaki, M. Kadono, M. Tanaka, M. Asano, and T. Senmaru Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion Endocrinology 151 2010 529 536
30. G. Hasegawa Decreased senescence marker protein-30 could be a factor that contributes to the worsening of glucose tolerance in normal aging Islets 2 2010 258 260
31. A. Ishigami, Y. Kondo, R. Nanba, T. Ohsawa, S. Handa, and S. Kubo SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span Biochem Biophys Res Commun 315 2004 575 580
32. 2 +-ATPase activity J Cell Biochem 86 2002 520 529
33. M. Yamaguchi, H. Misawa, S. Uchiyama, Y. Morooka, and Y. Tsurusaki Role of endogenous regucalcin in bone metabolism: bone loss is induced in regucalcin transgenic rats Int J Mol Med 10 2002 377 383
34. M. Yamaguchi, A. Igarashi, S. Uchiyama, and N. Sawada Hyperlipidemia is induced in regucalcin transgenic rats with increasing age Int J Mol Med 14 2004 647 651
35. M. Yamaguchi, and T. Nakagawa Change in lipid components in the adipose and liver tissues of regucalcin transgenic rats with increasing age: suppression of leptin and adiponectin gene expression Int J Mol Med 20 2007 323 328
36. P.J. Havel Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism Diabetes 53 2004 5143 5151
37. T. Roni, G. Lupattelli, and E. Mannarino The endocrine function of adipose tissue: an uptake Clin Endocrinol 64 2006 255 365
38. P.H. Weinstock, C.L. Bisgaier, K. Aalto-Setala, H. Radner, R. Ramarkrishnan, and S. Levak-Frank Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase in knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J Clin Invest 96 1995 2555 2568
39. A.H. Lichtman, S.K. Clinton, K. Liyama, P.W. Connelly, P. Libby, and M.I. Cybulsky Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurifdied diets with and without cholate Arterioscler Throb Vasc Biol 19 1999 1938 1944
40. M.C. Jong, and L.M. Havekes Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice Int J Tissue React 22 2000 59 66
41. S.J. Koopmans, M.C. Jong, I. Que, V.E. Dahlmans, H. Pijl, and J.K. Radder Hyperlipidemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1 Diabetologia 44 2001 437 443
42. H. Yagyu, E.P. Lutz, Y. Kako, S. Marks, Y. Hu, and S.Y. Choi Very low density lipoprotein (VLDL) receptor-deficient mice have reduced lipoprotein lipase activity mass with VLDL receptor deficiency J Biol Chem 277 2002 10037 10043
43. J.Y. Chen, B. Levy-Wilson, S. Goodart, and A.D. Cooper Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lock induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet J Biol Chem 277 2002 42588 42595
44. S. Fazio, and M.F. Linton Mouse models of hyperlipidemia and atherosclerosis Front Biosci 6 2001 D515 D525
45. H. Ono, H. Shibano, H. Katagiri, N. Yahagi, H. Sakoda, and Y. Onishi Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement Diabetes 52 2003 2905 2913
46. M. Isogai, N. Shimokawa, and M. Yamaguchi Hepatic calcium-binding protein regucalcin is released into the serum of rats administered orally carbon tetrachloride Mol Cell Biochem 131 1994 173 179
47. M. Isogai, K. Oishi, and M. Yamaguchi Serum release of hepatic calcium-binding protein regucalcin by liver injury with galactosamine administration in rats Mol Cell Biochem 136 1994 85 90
48. M. Yamaguchi, M. Isogai, and N. Shimada Potential sensitivity of hepatic specific protein regucalcin as a marker of chronic liver injury Mol Cell Biochem 167 1997 187 190
49. M. Yamaguchi Role of regucalcin in maintaining cell homeostasis and function (review) Int J Mol Med 15 2005 371 389
50. M. Yamaguchi Regucalcin and cell regulation: role as a suppressor in cell signaling Mol Cell Biochem 353 2011 101 137
51. M. Yamaguchi Regucalcin: genomics cell regulation and diseases 2012 Nova Science Publishers, Inc. New York, USA
52. J.K. Park, M.R. Ki, H.R. Lee, I.H. Hong, A.R. Ji, and A. Ishigami Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice Hepatology 51 2010 1766 1777
53. I.H. Hong, J.Y. Han, M.J. Goo, S.Y. Hwa, M.R. Ki, and J.K. Park Ascorbic acid deficiency accelerates aging of hepatic stellate cells with up-regulation of PPARγ Histol Histopathol 27 2012 171 179
54. H. Park, A. Ishigami, T. Shima, M. Mizuno, N. Maruyama, and K. Yamaguchi Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease J Gastroenterol 45 2010 426 434